Beyond AI Hype: The Unseen Alpha in Corporate Breakups and Spinoffs
The AI Efficiency Paradox in Financial Markets When Citadel founder Ken Griffin declared that artificial intelligence “fails to help hedge…
Microsoft is preparing to roll out a controversial new feature in Teams that will automatically track when employees are physically…
The AI Efficiency Paradox in Financial Markets When Citadel founder Ken Griffin declared that artificial intelligence “fails to help hedge…
Historic Agreement Prevents Theater Shutdown During Peak Season Broadway’s acting community has reached a landmark three-year labor agreement that successfully…
Ethernet Evolution for AI Demands Broadcom has launched the Thor Ultra, positioning it as the industry’s inaugural 800G AI Ethernet…
OpenAI Faces Backlash Over GPT-5 Mathematical Achievement Claims The artificial intelligence research community is embroiled in controversy following OpenAI’s claims…
Danish pharmaceutical giant Novo Nordisk has recruited American pharmaceutical veteran Greg Miley to lead global corporate affairs as the company faces mounting political pressure on drug pricing. The appointment comes during a major restructuring that includes cutting approximately 9,000 positions worldwide.
Novo Nordisk has reportedly hired former AbbVie executive Greg Miley as its new global head of corporate affairs, according to sources familiar with the matter. The appointment comes as the pharmaceutical industry faces increasing scrutiny from the Trump administration over drug pricing policies.
Strategic Time Infrastructure Targeted in Sophisticated Cyber Campaign China has leveled serious allegations against the United States, claiming the National…
Luminar’s Leadership Saga Takes Surprising Turn In a dramatic development that highlights the complex dynamics of corporate governance, Luminar founder…
Breakthrough in Hippo Pathway Targeting In a significant development for oncology therapeutics, the YAP/TEAD inhibitor VT3989 has demonstrated promising results…